Establishing potential shares and a fundraising facility through the issuance of the 10th series of stock acquisition rights
First written in FY2018. 4 of 5 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2020.
20 other companies' latest entry also says "Advanced".
- FY2020AdvancedAnnual report
「The 10th Series stock acquisition rights issued by the company were exercised as follows between 1 March 2020 and 18 May 2020: 98 stock acquisition rights exercised (100.0% of the total issued).」
All 98 of the 10th Series stock acquisition rights, representing 100% of the total issued, were exercised by 18 May 2020, resulting in the issuance of 9.8 million shares. Utilization of the funding facility was completed. - FY2020-Q3AdvancedAnnual report
「During the cumulative third quarter of the current fiscal year, the company increased stated capital by ¥58.768 million and capital surplus by ¥58.768 million through the exercise of stock acquisition rights.」
Through the exercise of the 10th Series stock acquisition rights, issued shares increased by 2.9 million during the cumulative third quarter of the current fiscal year, while stated capital and capital surplus each increased by ¥58.768 million. Utilization of the funding facility progressed. - FY2020-Q2AdvancedAnnual report
「Between 1 September 2019 and 30 September 2019, the number of issued shares increased by 200,000 through the exercise of stock acquisition rights.」
In September 2019, after the end of the quarter, 200,000 shares were issued through the exercise of the 10th Series stock acquisition rights, representing further utilization of the established funding facility. - FY2019-Q3AdvancedAnnual report
「During the cumulative third quarter of the current fiscal year, the company increased stated capital by ¥20.612 million and capital surplus by ¥20.612 million through the exercise of stock acquisition rights.」
During the cumulative third quarter of the current fiscal year, 800,000 shares were issued through the exercise of the 10th Series stock acquisition rights, increasing stated capital and capital surplus by ¥20.612 million each. Part of the established funding facility was drawn down. - FY2018First statedAnnual report
「10th Series of Stock Acquisition Rights (resolved by the Board of Directors on 30 January 2018)」
The company issued 135 10th Series stock acquisition rights for 13,500,000 underlying shares, with an exercise period from 16 February 2018 to 15 February 2020. The terms included an exercise-price adjustment clause, a minimum exercise price of ¥40, and a 10% cap on share ownership.